Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meehyung Cho

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|September 6, 2017
Considerations for pediatric trial designs and analysesMeehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Diabetes/Metabolism Research and Reviews|August 14, 2014
Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programmeDenis Raccah, Patrick Miossec, Virginie Esposito, et al.
Pharmaceutical Statistics|January 23, 2015
Adaptive and repeated cumulative meta-analyses of safety data during a new drug development processHui Quan, Yingqiu Ma, Yan Zheng, et al.
Pharmaceutical Statistics|March 3, 2023
Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpointHui Quan, Zhixing Xu, Junxiang Luo, et al.
Journal of Biopharmaceutical Statistics|January 22, 2013
Considerations for design and data analysis of noninferiority/superiority cardiovascular trialsHui Quan, Mingyu Li, Peng-Liang Zhao, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaClaude Gagné, Harold E Bays, Stuart R Weiss, et al.
Clinical Therapeutics|April 7, 2005
Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension studyLuis Masana, Pedro Mata, Claude Gagné, et al.
Pediatrics|September 6, 2005
Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemiaSarah B Clauss, Kathryn W Holmes, Paul Hopkins, et al.
The American Journal of Cardiology|June 15, 2004
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goalsTheodore Feldman, Michael Koren, William Insull, et al.
Clinical Cardiology|January 24, 2003
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemiaJonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|September 6, 2017
Considerations for pediatric trial designs and analysesMeehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Diabetes/Metabolism Research and Reviews|August 14, 2014
Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programmeDenis Raccah, Patrick Miossec, Virginie Esposito, et al.
Pharmaceutical Statistics|January 23, 2015
Adaptive and repeated cumulative meta-analyses of safety data during a new drug development processHui Quan, Yingqiu Ma, Yan Zheng, et al.
Pharmaceutical Statistics|March 3, 2023
Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpointHui Quan, Zhixing Xu, Junxiang Luo, et al.
Journal of Biopharmaceutical Statistics|January 22, 2013
Considerations for design and data analysis of noninferiority/superiority cardiovascular trialsHui Quan, Mingyu Li, Peng-Liang Zhao, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaClaude Gagné, Harold E Bays, Stuart R Weiss, et al.
Clinical Therapeutics|April 7, 2005
Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension studyLuis Masana, Pedro Mata, Claude Gagné, et al.
Pediatrics|September 6, 2005
Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemiaSarah B Clauss, Kathryn W Holmes, Paul Hopkins, et al.
The American Journal of Cardiology|June 15, 2004
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goalsTheodore Feldman, Michael Koren, William Insull, et al.
Clinical Cardiology|January 24, 2003
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemiaJonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, et al.
Pageof 1